Global Vial and Prefilled Syringe Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 161233
- Pages: 150
-
Format:
Summary
The global Vial and Prefilled Syringe market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Glass Vial and Prefilled Syringe
Polymer Vial and Prefilled Syringe
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
BD (US)
Gerresheimer (DE)
Nipro Corporation (JP)
Schott forma vitrum (DE)
Ompi (IT)
Baxter BioPharma Solution (US)
ROVI CM (ES)
Terumo (JP)
Vetter (DE)
Unilife Corporation (US)
Taisei Kako (JP)
Roselabs Group (IN)
ARTE CORPORATION (JP)
Weigao Group Medical Polymer (CN)
Zibo Minkang Pharmaceutical (CN)
Shandong Pharmaceutical Glass (CN)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Antithrombotics
Vaccines
Autoimmune Diseases
Anti-inflammatory Drugs
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Vial and Prefilled Syringe of Research
1.1.1 Definition
1.1.2 Specifications of Vial and Prefilled Syringe
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Glass Vial and Prefilled Syringe Overview
1.2.1.2 Polymer Vial and Prefilled Syringe Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Antithrombotics
1.3.1.2 Vaccines
1.3.1.3 Autoimmune Diseases
1.3.1.4 Anti-inflammatory Drugs
1.3.1.5 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Glass Vial and Prefilled Syringe Market Size 2018-2023
3.1.1.1 Global Glass Vial and Prefilled Syringe Market Size and Growth Rate 2018-2023
3.1.1.2 Global Glass Vial and Prefilled Syringe Market Size by Region 2018-2023
3.1.2 Polymer Vial and Prefilled Syringe Market Size 2018-2023
3.1.2.1 Global Polymer Vial and Prefilled Syringe Market Size and Growth Rate 2018-2023
3.1.2.2 Global Polymer Vial and Prefilled Syringe Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Glass Vial and Prefilled Syringe Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Glass Vial and Prefilled Syringe Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Glass Vial and Prefilled Syringe Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Polymer Vial and Prefilled Syringe Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Polymer Vial and Prefilled Syringe Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Polymer Vial and Prefilled Syringe Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Antithrombotics Market Size 2018-2023
4.1.1.1 Global Antithrombotics Market Size and Growth Rate 2018-2023
4.1.1.2 Global Antithrombotics Market Size by Region 2018-2023
4.1.2 Vaccines Market Size 2018-2023
4.1.2.1 Global Vaccines Market Size and Growth Rate 2018-2023
4.1.2.2 Global Vaccines Market Size by Region 2018-2023
4.1.3 Autoimmune Diseases Market Size 2018-2023
4.1.3.1 Global Autoimmune Diseases Market Size and Growth Rate 2018-2023
4.1.3.2 Global Autoimmune Diseases Market Size by Region 2018-2023
4.1.4 Anti-inflammatory Drugs Market Size 2018-2023
4.1.4.1 Global Anti-inflammatory Drugs Market Size and Growth Rate 2018-2023
4.1.4.2 Global Anti-inflammatory Drugs Market Size by Region 2018-2023
4.1.5 Others Market Size 2018-2023
4.1.5.1 Global Others Market Size and Growth Rate 2018-2023
4.1.5.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Antithrombotics Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Antithrombotics Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Antithrombotics Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Vaccines Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Vaccines Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Vaccines Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Autoimmune Diseases Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Autoimmune Diseases Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Autoimmune Diseases Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Anti-inflammatory Drugs Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Anti-inflammatory Drugs Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Anti-inflammatory Drugs Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Others Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Vial and Prefilled Syringe Market Competition
7.1.1 Global Vial and Prefilled Syringe Market by Companies
7.1.2 Global Vial and Prefilled Syringe Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 BD (US)
8.1.1 BD (US) Company Profile
8.1.2 BD (US) Product Portfolio
8.1.3 BD (US) Business Performance
8.1.4 BD (US) Development Overview
8.2 Gerresheimer (DE)
8.2.1 Gerresheimer (DE) Company Profile
8.2.2 Gerresheimer (DE) Product Portfolio
8.2.3 Gerresheimer (DE) Business Performance
8.2.4 Gerresheimer (DE) Development Overview
8.3 Nipro Corporation (JP)
8.3.1 Nipro Corporation (JP) Company Profile
8.3.2 Nipro Corporation (JP) Product Portfolio
8.3.3 Nipro Corporation (JP) Business Performance
8.3.4 Nipro Corporation (JP) Development Overview
8.4 Schott forma vitrum (DE)
8.4.1 Schott forma vitrum (DE) Company Profile
8.4.2 Schott forma vitrum (DE) Product Portfolio
8.4.3 Schott forma vitrum (DE) Business Performance
8.4.4 Schott forma vitrum (DE) Development Overview
8.5 Ompi (IT)
8.5.1 Ompi (IT) Company Profile
8.5.2 Ompi (IT) Product Portfolio
8.5.3 Ompi (IT) Business Performance
8.5.4 Ompi (IT) Development Overview
8.6 Baxter BioPharma Solution (US)
8.6.1 Baxter BioPharma Solution (US) Company Profile
8.6.2 Baxter BioPharma Solution (US) Product Portfolio
8.6.3 Baxter BioPharma Solution (US) Business Performance
8.6.4 Baxter BioPharma Solution (US) Development Overview
8.7 ROVI CM (ES)
8.7.1 ROVI CM (ES) Company Profile
8.7.2 ROVI CM (ES) Product Portfolio
8.7.3 ROVI CM (ES) Business Performance
8.7.4 ROVI CM (ES) Development Overview
8.8 Terumo (JP)
8.8.1 Terumo (JP) Company Profile
8.8.2 Terumo (JP) Product Portfolio
8.8.3 Terumo (JP) Business Performance
8.8.4 Terumo (JP) Development Overview
8.9 Vetter (DE)
8.9.1 Vetter (DE) Company Profile
8.9.2 Vetter (DE) Product Portfolio
8.9.3 Vetter (DE) Business Performance
8.9.4 Vetter (DE) Development Overview
8.10 Unilife Corporation (US)
8.10.1 Unilife Corporation (US) Company Profile
8.10.2 Unilife Corporation (US) Product Portfolio
8.10.3 Unilife Corporation (US) Business Performance
8.10.4 Unilife Corporation (US) Development Overview
8.11 Taisei Kako (JP)
8.11.1 Taisei Kako (JP) Company Profile
8.11.2 Taisei Kako (JP) Product Portfolio
8.11.3 Taisei Kako (JP) Business Performance
8.11.4 Taisei Kako (JP) Development Overview
8.12 Roselabs Group (IN)
8.12.1 Roselabs Group (IN) Company Profile
8.12.2 Roselabs Group (IN) Product Portfolio
8.12.3 Roselabs Group (IN) Business Performance
8.12.4 Roselabs Group (IN) Development Overview
8.13 ARTE CORPORATION (JP)
8.13.1 ARTE CORPORATION (JP) Company Profile
8.13.2 ARTE CORPORATION (JP) Product Portfolio
8.13.3 ARTE CORPORATION (JP) Business Performance
8.13.4 ARTE CORPORATION (JP) Development Overview
8.14 Weigao Group Medical Polymer (CN)
8.14.1 Weigao Group Medical Polymer (CN) Company Profile
8.14.2 Weigao Group Medical Polymer (CN) Product Portfolio
8.14.3 Weigao Group Medical Polymer (CN) Business Performance
8.14.4 Weigao Group Medical Polymer (CN) Development Overview
8.15 Zibo Minkang Pharmaceutical (CN)
8.15.1 Zibo Minkang Pharmaceutical (CN) Company Profile
8.15.2 Zibo Minkang Pharmaceutical (CN) Product Portfolio
8.15.3 Zibo Minkang Pharmaceutical (CN) Business Performance
8.15.4 Zibo Minkang Pharmaceutical (CN) Development Overview
8.16 Shandong Pharmaceutical Glass (CN)
8.16.1 Shandong Pharmaceutical Glass (CN) Company Profile
8.16.2 Shandong Pharmaceutical Glass (CN) Product Portfolio
8.16.3 Shandong Pharmaceutical Glass (CN) Business Performance
8.16.4 Shandong Pharmaceutical Glass (CN) Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
